-- 
Cellectis, Genfit, Metropole Television: French Equity Preview

-- B y   F r a n k   C o n n e l l y
-- 
2011-08-24T18:53:44Z

-- http://www.bloomberg.com/news/2011-08-24/cellectis-genfit-metropole-television-french-equity-preview.html
The following companies’ shares may
be active in Paris. Symbols are in parentheses after company
names and prices are from the last close.  France’s CAC 40 Index rose 55.18, or 1.8 percent, to
3,139.55. The  SBF 120 Index (SBF120)  advanced 1.8 percent.  Cellectis (ALCLS)  SA: The drug developer signed a
development and license agreement with Minneapolis-based
Recombinetics on the creation of large livestock. The shares
were unchanged at 6 euros.  Genfit (ALGFT)  : The pharmaceutical company said it
secured as much as 5.3 million euros of financing. The stock
fell 0.4 percent to 2.62 euros.  M6- Metropole Television SA (MMT)  : France’s second-
largest commercial television company said it extended an
agreement with CBS Studios International to bring its series and
films to France. The shares climbed 1.7 percent to 14.36 euros.  To contact the reporter on this story:
Frank Connelly in Paris at 
 fconnelly@bloomberg.net   To contact the editor responsible for this story:
Andrew Rummer at 
 arummer@bloomberg.net  